IFNGR2 and central nervous system cancer: IFNGR2 was predominantly expressed in monocytes, M1 macrophages, and MES-like malignant cells (Figure 6B), aligning with previous findings that IFNGR2 is preferentially expressed by monocyte/macrophage populations within the glioma microenvironment (65).